Article
Cancer causes metabolic perturbations associated with reduced insulin-stimulated glucose…
medRxiv · 2019 · Han, X.; Raun, S.; Carlsson, M.; Sjoberg, K. A.; Henriquez-Olguin, C.; Ali, M.; Lundsgaard, A.; Fritzen, A. M.; Moller, L. L. V.; Li, Z.; Li, J.; Jensen, T. E.; Kiens, B.; Sylow, L.
Key facts
| Title | Cancer causes metabolic perturbations associated with reduced insulin-stimulated glucose uptake in peripheral tissues and impaired muscle microvascular perfusion |
|---|---|
| First author | Han, X.; Raun, S.; Carlsson, M.; Sjoberg, K. A.; Henriquez-Olguin, C.; Ali, M.; Lundsgaard, A.; Fritzen, A. M.; Moller, L. L. V.; Li, Z.; Li, J.; Jensen, T. E.; Kiens, B.; Sylow, L. |
| Journal | medRxiv |
| Published | Dec 28, 2019 |
| DOI | 10.1101/734764 |
| Devices mentioned | K012205, K040227, K061396, K062324, K070792, K093563, K110414, K121223, K130499, K132165, K181264, K893117 and 8 more |
| Product codes mentioned | CFR, CGA, IYN, LLZ, MHX, NBW, ITX, IYO, QIH |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1